Lunai Bioworks Inc. Basic Shares Outstanding (Weighted Average)
Lunai Bioworks Inc. (LNAI) reported Basic Shares Outstanding (Weighted Average) of 24.99 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-15
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 24.99M shares, a 53.97% increase year-over-year.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 23.48M shares, a 45.11% increase year-over-year.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 22.52M shares, a 40.76% increase year-over-year.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 611.83M shares, a 305.77% increase year-over-year.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 165.06M shares, a 69.27% increase from fiscal 2024.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 97.51M shares, a 73.31% increase from fiscal 2023.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 56.27M shares, a 7.11% increase from fiscal 2022.
- Lunai Bioworks Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 52.53M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 24.99M shares 10-Q · filed 2026-05-15 | 24.24M shares derived: average of 2 quarters · filed 2026-05-15 | 23.74M shares 10-Q · filed 2026-05-15 | 170.71M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | 23.48M shares 10-Q · filed 2026-02-17 | 23.13M shares 10-Q · filed 2026-02-17 | 219.28M shares derived: average of 3 quarters · filed 2026-02-17 | 168.52M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2025-09-30 | 22.52M shares 10-Q · filed 2025-11-14 | 317.18M shares derived: average of 2 quarters · filed 2025-11-14 | 216.86M shares derived: average of 3 quarters · filed 2026-05-15 | 166.69M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2025-06-30 | 611.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 314.03M shares derived: average of 2 quarters · filed 2026-05-15 | 214.75M shares derived: average of 3 quarters · filed 2026-05-15 | 165.06M shares 10-K · filed 2025-09-29 | ||||
| 2025-03-31 | 16.23M shares 10-Q · filed 2026-05-15 | 162.33M shares 10-Q · filed 2025-05-15 | 16.21M shares derived: average of 2 quarters · filed 2026-05-15 | 16.14M shares 10-Q · filed 2026-05-15 | 161.38M shares 10-Q · filed 2025-05-15 | 49.80M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | 16.18M shares 10-Q · filed 2026-02-17 | 161.83M shares 10-Q · filed 2025-02-19 | 16.09M shares 10-Q · filed 2026-02-17 | 160.91M shares 10-Q · filed 2025-02-19 | 60.99M shares derived: average of 3 quarters · filed 2026-02-17 | 73.05M shares derived: average of 4 quarters · filed 2026-02-17 | ||
| 2024-09-30 | 16.00M shares 10-Q · filed 2025-11-14 | 156.57M shares 10-Q · filed 2024-11-14 | 83.39M shares derived: average of 2 quarters · filed 2025-11-14 | 92.01M shares derived: average of 3 quarters · filed 2025-11-14 | 85.47M shares derived: average of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | 150.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 130.02M shares derived: average of 2 quarters · filed 2025-09-29 | 108.63M shares derived: average of 3 quarters · filed 2025-09-29 | 97.51M shares 10-K · filed 2025-09-29 | 96.25M shares 10-K · filed 2024-10-10 | |||
| 2024-03-31 | 109.25M shares 10-Q · filed 2025-05-15 | 107.48M shares 10-Q · filed 2024-05-15 | 87.55M shares derived: average of 2 quarters · filed 2025-05-15 | 79.75M shares 10-Q · filed 2025-05-15 | 79.17M shares 10-Q · filed 2024-05-15 | 74.52M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 65.85M shares 10-Q · filed 2025-02-19 | 65.17M shares 10-Q · filed 2025-02-19 | 62.94M shares derived: average of 3 quarters · filed 2025-02-19 | 61.20M shares derived: average of 4 quarters · filed 2025-02-19 | ||||
| 2023-09-30 | 64.48M shares 10-Q/A · filed 2025-02-19 | 61.48M shares derived: average of 2 quarters · filed 2025-02-19 | 59.65M shares derived: average of 3 quarters · filed 2025-02-19 | 58.61M shares derived: average of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | 58.49M shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | 57.23M shares derived: average of 2 quarters · filed 2025-02-19 | 56.66M shares derived: average of 3 quarters · filed 2025-02-19 | 56.27M shares 10-K/A · filed 2025-02-19 | ||||
| 2023-03-31 | 55.97M shares 10-Q/A · filed 2025-02-19 | 55.74M shares derived: average of 2 quarters · filed 2025-02-19 | 55.52M shares 10-Q/A · filed 2025-02-19 | |||||
| 2022-12-31 | 55.51M shares 10-Q · filed 2024-02-14 | 55.30M shares 10-Q · filed 2024-02-14 | ||||||
| 2022-09-30 | 55.10M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 52.53M shares 10-K · filed 2023-10-02 | |||||||
| 2017-06-30 | 12.27M shares 10-K · filed 2017-11-20 | |||||||
| 2017-03-31 | 9.53M shares 10-Q · filed 2017-05-15 | 9.53M shares derived: average of 2 quarters · filed 2017-05-15 | 9.53M shares 10-Q · filed 2017-05-15 | 9.53M shares derived: average of 4 quarters · filed 2017-11-20 | ||||
| 2016-12-31 | 9.53M shares 10-Q · filed 2017-02-14 | 9.53M shares 10-Q · filed 2017-02-14 | 9.53M shares derived: average of 3 quarters · filed 2017-11-20 | 9.53M shares derived: average of 4 quarters · filed 2017-11-20 | ||||
| 2016-09-30 | 9.53M shares 10-Q · filed 2016-11-14 | 9.53M shares derived: average of 2 quarters · filed 2017-11-20 | 9.53M shares derived: average of 3 quarters · filed 2017-11-20 | 9.53M shares derived: average of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | 9.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-20 | 9.53M shares derived: average of 2 quarters · filed 2017-11-20 | 9.53M shares derived: average of 3 quarters · filed 2017-11-20 | 9.53M shares 10-K · filed 2017-11-20 | ||||
| 2016-03-31 | 9.53M shares 10-Q · filed 2017-05-15 | 9.53M shares derived: average of 2 quarters · filed 2017-05-15 | 9.53M shares 10-Q · filed 2017-05-15 | 9.53M shares derived: average of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | 9.53M shares 10-Q · filed 2017-02-14 | 9.53M shares 10-Q · filed 2017-02-14 | 9.53M shares derived: average of 3 quarters · filed 2017-02-14 | 9.53M shares derived: average of 4 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | 9.53M shares 10-Q · filed 2016-11-14 | 9.53M shares derived: average of 2 quarters · filed 2016-11-14 | 9.53M shares derived: average of 3 quarters · filed 2016-11-14 | 9.38M shares derived: average of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | 9.53M shares derived: 10-K 6 month − 10-Q 3 month · filed 2016-09-28 | 9.53M shares 10-K · filed 2016-09-28 | 9.33M shares derived: average of 3 quarters · filed 2016-09-28 | 9.02M shares derived: average of 4 quarters · filed 2016-09-28 | ||||
| 2015-03-31 | 9.53M shares 10-Q · filed 2016-05-13 | 9.23M shares derived: average of 2 quarters · filed 2016-05-13 | 8.35M shares 10-Q · filed 2016-05-13 | 8.69M shares derived: average of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | 8.93M shares 10-Q · filed 2016-02-12 | 8.50M shares 10-Q · filed 2016-02-12 | 8.41M shares derived: average of 3 quarters · filed 2016-02-12 | 7.50M shares 10-K · filed 2016-09-28 | ||||
| 2014-09-30 | 8.08M shares 10-Q · filed 2015-11-13 | 8.16M shares derived: average of 2 quarters · filed 2015-11-13 | 7.73M shares derived: average of 3 quarters · filed 2015-11-13 | |||||
| 2014-06-30 | 8.23M shares derived: 10-KT 6 month − 10-Q 3 month · filed 2015-09-28 | 7.56M shares 10-KT · filed 2015-09-28 | ||||||
| 2014-03-31 | 6.88M shares 10-Q · filed 2015-05-13 | |||||||
| 2013-12-31 | 3.56M shares 10-KT · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |